Cargando…
Guillain-Barré Syndrome After Ad26.COV2.S Vaccination
Patient: Male, 66-year-old Final Diagnosis: Guillain-Barré syndrome Symptoms: Paresthesia • weakness Medication: — Clinical Procedure: — Specialty: Immunology • Infectious Diseases • Neurology • Rehabilitation OBJECTIVE: Unknown etiology Background: Since December 2020, multiple vaccines have mobili...
Autores principales: | Thant, Hein Linn, Morgan, Richard, Paese, Mario M., Persaud, Trevor, Diaz, Jose, Hurtado, Lina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855329/ https://www.ncbi.nlm.nih.gov/pubmed/35157644 http://dx.doi.org/10.12659/AJCR.935275 |
Ejemplares similares
-
Ad26.COV2-S: Guillain-Barre syndrome: case report
Publicado: (2021) -
A Rare Variant of Guillain-Barre Syndrome Following Ad26.COV2.S Vaccination
por: Morehouse, Zachary P, et al.
Publicado: (2021) -
Guillain-Barré syndrome and fulminant encephalomyelitis following Ad26.COV2.S vaccination: double jeopardy
por: Stefanou, Maria Ioanna, et al.
Publicado: (2022) -
Ad26.cov2-s: Guillain Barre syndrome and fulminant encephalomyelitis: case report
Publicado: (2022) -
Facial Diplegia: A Rare, Atypical Variant of Guillain-Barré Syndrome and Ad26.COV2.S Vaccine
por: Jain, Esha, et al.
Publicado: (2021)